CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 99 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Grant or award · Restricted Stock Units | +46,875 | 46,875 | ||
| 2023-03-02 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Grant or award · Stock Option (right to buy) | +93,750 | 93,750 | ||
| 2023-03-02 | BILINSKY IGOR Chief Operating Officer | Grant or award · Restricted Stock Units | +42,190 | 42,190 | ||
| 2023-03-02 | BILINSKY IGOR Chief Operating Officer | Grant or award · Stock Option (right to buy) | +84,380 | 84,380 | ||
| 2023-03-02 | Bellemin Jean-Marc Chief Financial Officer | Grant or award · Stock Option (right to buy) | +168,750 | 168,750 | ||
| 2023-01-17 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +11,248 | 32,796 | ||
| 2023-01-17 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −4,678 | $6.43 | $30K | 28,118 |
| 2023-01-17 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −11,248 | 22,502 | ||
| 2023-01-17 | BILINSKY IGOR Chief Operating Officer | Option exercise | +11,248 | 29,049 | ||
| 2023-01-17 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −4,671 | $6.43 | $30K | 24,378 |
| 2023-01-17 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −11,248 | 22,502 | ||
| 2023-01-17 | Vogt Frederick G Interim CEO & General Counsel | Option exercise | +83,325 | 85,325 | ||
| 2023-01-17 | Vogt Frederick G Interim CEO & General Counsel | Shares withheld for taxes | −36,441 | $6.43 | $234K | 48,884 |
| 2023-01-17 | Vogt Frederick G Interim CEO & General Counsel | Option exercise · Restricted Stock Units | −83,325 | 166,675 | ||
| 2023-01-03 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise | +19,690 | 32,571 | ||
| 2023-01-03 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Shares withheld for taxes | −11,023 | $6.11 | $67K | 21,548 |
| 2023-01-03 | GRAF FINCKENSTEIN FRIEDRICH Chief Medical Officer | Option exercise · Restricted Stock Units | −19,690 | 0 | ||
| 2023-01-03 | BILINSKY IGOR Chief Operating Officer | Option exercise | +18,850 | 28,354 | ||
| 2023-01-03 | BILINSKY IGOR Chief Operating Officer | Shares withheld for taxes | −10,553 | $6.11 | $64K | 17,801 |
| 2023-01-03 | BILINSKY IGOR Chief Operating Officer | Option exercise · Restricted Stock Units | −18,850 | 0 |
Page 19 of 23 · 446 trades